Trial
NCT02274012
Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
Boehringer Ingelheim
Condition
HER-2 Positive Gastric Cancer
Intervention
Afatinib
Why stopped
Former PI left institution and had plans to continue at another institution.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-14